Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1778-1783

  Yamamoto, Nobuchika ^a,b   Sakai, Fumihiko ^a,b   Yamazaki, Harumi ^a,b   Kawai, Yoshio ^a,b   Nakahara, Kunio ^a,b   Okuhara, Masakuni ^a,b  

^a ASTELLAS PHARMA INC   (Japan)

^b Department of Biological Science ^*  (Japan)

Author keywords

adjuvant arthritis; bone mineral density; cartilage; interleukin 1; tumor necrosis factor

Indexed keywords

AURANOFIN; DEXAMETHASONE; DICLOFENAC; FR 133605; INDOMETACIN; INTERLEUKIN 1; PENICILLAMINE; PIROXICAM; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; JOINT DESTRUCTION; PRIORITY JOURNAL; RAT;

ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; BONE RESORPTION; CARTILAGE, ARTICULAR; CYTOKINES; FEMALE; GLYCOSAMINOGLYCANS; INTERLEUKIN-1; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MONOCYTES; PYRIDINES; RATS; RATS, INBRED LEW; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029804148     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
2. Shore A, Jaglal S, Keystone EC: Enhanced interleukin-1 generation by monocytes is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986;65:293-302.
3. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D: Release of tumor necrosis factor-α from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988;141:2388-93.
4. Mizel SB, Dayer JM, Krane SM, Mergenhagen SR: Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1). Proc Natl Acad Sci USA 1981;78:2474-7.
5. Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA: Interleukin-6 is involved in interleukin 1-induced activities. Eur J Immunol 1988;18:957-9.
6. Strieter RM, Kunkel SL, Showell HJ, et al.: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 1989;243:1467-9.
7. Matsushima K, Morishita K, Yshimura T, et al.: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
8. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 1989;68:31-6.
9. Keeling PE, Rifas L, Harris SA, et al.: Evidence for interleukin-1 production by cultured normal human osteoblast-Iike cells. J Bone Miner Res 1991;6:827-33.
10. Gowen M, Mundy GR: Action of recombinant interleukin-1, interleukin-2 and interferon gamma on bone resorption in vitro. J Immunol 1986;136:2478-82.
11. Johnson RA, Boyce BF, Mundy GR, Roodman GD: Tumors producing human necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 1989;124:1424-7.
12. Thompson BM, Mundy GR, Chambers TJ: Tumor necrosis factors a and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-9.
13. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russel RG: An interleukin-1 like factor stimulates bone resorption in vitro. Nature 1983;306:378-80.
14. Thomas BM, Mundy GR, Chambers TJ: Tumor necrosis factor a and β induce osteoblastic cells to stimulate osteoclast bone resorption. J Immunol 1987;138:775-80.
15. Pfeilschifter J, Chenu C, Bird A, et al.: Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 1989;4:113-8.
16. Gowen M, Chapman K, Littlewood A, Hughes D, Evans D, Russell G: Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not osteotropic hormones. Endocrinology 1990;126:1250-4.
17. Littlewood A, Russell J, Harvey G, Hughes DE, Russell RGG, Gowen M: The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 1991;129:1513-20.
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 1983;65:55-63.
19. Kilian PL, Kaffka KL, Stern AS, et al.: Interleukin-1 a and interleukin-β bind to the same receptor on T cells. J Immunol 1986;136:4509-14.
20. Shino A, Tsukuda R, Odaka H, Kitazaki T, Tsuda M, Matsuo T: Suppressive effect of iproflavone on bone depletion in the experimental diabetic rat: Dose response of ipriflavone. Life Sci 1988;42:1123-30.
21. Pozo ED, Graeber M, Elford P, Payne T: Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A. Arthritis Rheum 1990;33:241-52.
22. Farndale RW, Sayers CA, Barrett AJ: A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage culture. Connect Tissue Res 1982;9:247-8.
23. Wright V, Amos R: Do drugs change the course of rheumatoid arthritis? BMJ 1980;280:964-6.
24. McConkey B, Crockson RA, Crockson AP, Wilkinson AR. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med 1973;42:785-91.
25. Iannauzzi L, Dawson N, Zein N, Kushner I: Does drug therapy slow radiographic deterioration in rheumatoid arthritis? New Engl J Med 1983;309:1023-8.
26. Hall GM, Hall ML, Ell PJ, Doyle DV, Specter TD: Bone density of the hip and spine in post menopausal rheumatoid arthritis (RA) and the effect of low dose steroids (abstr). Br J Rheumatol 1991;(suppl 2)30:53.
27. Schindler R, Ghezzi P, Dinarello CA: IFN-γ suppresses IL-1 but not Jipopolysaccharide-induced transcription of IL-1. J Immunol 1990;144:2216-22.